Skip to content
WeighLab

Lean Meds vs No BS RX

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Lean Meds

Provider comparison

Cost-first shoppers who want a genuinely flat all-dose price and named pharmacies, and who will read the $49 headline as the annual plan it is.

Semaglutide / month
$79/moMonth-to-month, flat at every dose (the advertised $49 is the 12-month plan)
Tirzepatide / month
$109/moMonth-to-month, flat at every dose (the advertised $95 is the 12-month plan)
Index 84/100 · Grade BChecked September 2026

No BS RX

Provider comparison

Someone who wants every term and every dose level comparable without starting an intake to see a price.

Semaglutide / month
$149/moMonth-to-month, same price at every dose ($390 for 12 weeks, $790 for 24, $1,551 for 52; oral $174/mo; low-dose program $115/mo)
Tirzepatide / month
$225/moMonth-to-month, same price at every dose ($548 for 12 weeks, $1,142 for 24, $2,225 for 52; low-dose program $115/mo)
Index 83/100 · Grade BChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Lean Meds has the higher Cost-Efficiency Index: 84/100 versus 83/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Lean Meds
All 50 states
No BS RX
Not disclosed

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Lean Meds

No BS RX

Semaglutide / month
Lean Meds: $79/moMonth-to-month, flat at every dose (the advertised $49 is the 12-month plan)
No BS RX: $149/moMonth-to-month, same price at every dose ($390 for 12 weeks, $790 for 24, $1,551 for 52; oral $174/mo; low-dose program $115/mo)
Tirzepatide / month
Lean Meds: $109/moMonth-to-month, flat at every dose (the advertised $95 is the 12-month plan)
No BS RX: $225/moMonth-to-month, same price at every dose ($548 for 12 weeks, $1,142 for 24, $2,225 for 52; low-dose program $115/mo)
Semaglutide / year (modeled)
Lean Meds: $948
No BS RX: $1,788
Tirzepatide / year (modeled)
Lean Meds: $1,308
No BS RX: $2,700
State availability
Lean Meds: All 50 states
No BS RX: Not disclosed
Oral / sublingual option listed
Lean Meds: Not listed
No BS RX: Yes
Brand-name access listed
Lean Meds: Not confirmed
No BS RX: Not confirmed
Provider facts checked
Lean Meds: September 2026
No BS RX: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Lean Meds

Cost-first shoppers who want a genuinely flat all-dose price and named pharmacies, and who will read the $49 headline as the annual plan it is.

Reasons to consider it

  • A flat rate at every dose on both molecules, stated as such, so the price does not climb as a provider titrates
  • Names all four pharmacies in its network with addresses, phone numbers and websites, and states the 503A designation in the footer of every page
  • The full four-rung ladder for each molecule is printed on one page, so a reader can see what a commitment actually saves

What to weigh up

  • The homepage sells "Starting at $49/mo — same price every month, first order and every order after"; $49 is the twelve-month semaglutide plan and the month-to-month rate is $79
  • A homepage chip reads "No auto rebill" while the terms say the payment method is automatically charged at recurring intervals until you cancel
  • Every offer page runs a countdown reading "Price increases in" with no dated deadline behind it

No BS RX

Someone who wants every term and every dose level comparable without starting an intake to see a price.

Reasons to consider it

  • Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
  • "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $115 in its hero really is a month-to-month rate
  • Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself

What to weigh up

  • Prepaying barely helps on the low-dose programs: twelve weeks cost $340, against $115 a month
  • The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
  • The Terms name four pharmacies and no operating company

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Lean MedsNo BS RX
Normalized Cost/Month
Lean Meds:
97/100
No BS RX:
91/100
Price Transparency
Lean Meds:
97/100
No BS RX:
94/100
Nationwide Access
Lean Meds:
86/100
No BS RX:
62/100
Formulation Options
Lean Meds:
66/100
No BS RX:
90/100
Clinical Oversight
Lean Meds:
73/100
No BS RX:
74/100
Contract Flexibility
Lean Meds:
67/100
No BS RX:
78/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.